Prim, S.A. Company Profile

Background

Overview

Prim, S.A. is a Spanish healthcare technology company specializing in the design, manufacturing, and distribution of medical instruments, orthopedic supplies, and mobility products. Founded in 1870 by Pedro Prim Fernández, the company has a rich history of over 150 years in the healthcare sector. Headquartered in Móstoles, Spain, Prim, S.A. operates multiple factories and specialized workshops across the country and exports its products to over 93 countries.

Mission and Vision

Prim, S.A. is committed to improving people's lives by providing innovative healthcare solutions. The company's mission focuses on enhancing the quality of life through advanced medical technologies and mobility products. Its vision is to be a leading provider in the healthcare sector, recognized for excellence, innovation, and customer satisfaction.

Primary Area of Focus

The company's primary areas of focus include:

• Medical Instruments and Supplies: Offering a wide range of products such as collars, clavicles, arm slings, hand and finger supports, shoulder, elbow, and wrist devices.

• Orthopedic Supplies: Providing supports and braces for various body parts, including lower limbs, shoulder, and back supports, bands, corsets, hyperextension braces, and thoracic protectors.

• Mobility Products: Developing products aimed at enhancing mobility and rehabilitation, catering to diverse patient needs.

Industry Significance

As one of the oldest companies in Spain's healthcare sector, Prim, S.A. holds a significant position in the market. Its extensive product range and commitment to quality have established it as a trusted partner for healthcare professionals and patients alike. The company's inclusion in the IBEX Top Dividendo index in February 2025 underscores its financial stability and investor confidence.

Key Strategic Focus

Core Objectives

• Growth and Expansion: Pursuing both organic growth and strategic acquisitions to expand product offerings and market reach.

• Innovation: Investing in research and development to introduce cutting-edge medical technologies and mobility solutions.

• Operational Efficiency: Enhancing operational processes to improve profitability and customer satisfaction.

Specific Areas of Specialization

• Medical Technologies: Developing advanced medical instruments and orthopedic supplies.

• Mobility and Healthcare Products: Creating products that aid in rehabilitation and improve patient mobility.

Key Technologies Utilized

• 3D Printing: Through its subsidiary Herbitas, Prim, S.A. acquired Led3D Newfeet in 2024, which offers 3D printing technology for creating custom orthotic insoles.

• Digitalization: Investing in digital platforms and technologies to enhance product development and customer engagement.

Primary Markets and Conditions Targeted

• Healthcare Sector: Supplying hospitals, clinics, and rehabilitation centers with medical instruments and orthopedic supplies.

• International Markets: Expanding presence in over 93 countries, including recent entries into Japan and China.

Financials and Funding

Funding History

Prim, S.A. has been publicly traded on the Madrid Stock Exchange since 1985, under the ticker symbol PRM. The company has a history of strategic acquisitions to bolster its market position and product offerings.

Total Funds Raised

Specific details regarding the total funds raised through public offerings are not publicly disclosed.

Recent Funding Rounds

Recent financial activities include:

• Acquisitions: In 2022, Prim, S.A. acquired Herbitas, Teyder, Easytech, and a stake in Aura Robotics, enhancing its technological capabilities and market presence.

• Dividend Distribution: In 2024, the company distributed €7.6 million in dividends, reflecting its commitment to shareholder returns.

Notable Investors

While specific investor details are not publicly disclosed, the company's inclusion in the IBEX Top Dividendo index indicates strong institutional interest and investor confidence.

Intended Utilization of Capital

The capital raised and generated is primarily utilized for:

• Strategic Acquisitions: To expand product offerings and enter new markets.

• Research and Development: Investing in innovation to develop new products and technologies.

• Operational Improvements: Enhancing efficiency and scalability of operations.

Pipeline Development

Key Pipeline Candidates

Prim, S.A. focuses on developing:

• Custom Orthotic Solutions: Leveraging 3D printing technology for personalized orthotic insoles.

• Advanced Mobility Aids: Innovative products designed to improve patient mobility and rehabilitation outcomes.

Stages of Clinical Trials or Product Development

Specific details regarding clinical trials are not publicly disclosed. However, the company is actively involved in product development, particularly in integrating 3D printing technologies for custom orthotics.

Target Conditions

The products aim to address various orthopedic and mobility-related conditions, including:

• Foot Deformities: Through custom orthotic insoles.

• Rehabilitation Needs: Providing mobility aids for post-surgical recovery and chronic conditions.

Relevant Timelines for Anticipated Milestones

While specific timelines are not publicly disclosed, the company continues to invest in research and development to bring innovative products to market.

Technological Platform and Innovation

Proprietary Technologies

• 3D Printing for Orthotics: Through the acquisition of Led3D Newfeet, Prim, S.A. has integrated 3D printing technology to create custom orthotic insoles, enhancing product personalization and patient comfort.

Significant Scientific Methods

• Digitalization: Implementing digital platforms for product development, customer engagement, and operational efficiency.

• Lean Manufacturing: Adopting lean principles to optimize production processes and reduce waste.

AI-Driven Capabilities

While specific AI applications are not detailed, the company's investment in digitalization suggests potential future integration of AI technologies in product development and customer service.

Leadership Team

Key Executives

• Lucía Comenge: President of Prim, S.A., overseeing strategic direction and operations.

• Juan Manuel Alba: International Manager, responsible for expanding the company's global presence.

• Ignacio Bravo Marín: Person in charge of international relations and partnerships.

Professional Backgrounds

• Lucía Comenge: With a background in business administration, Lucía has led Prim, S.A. through significant growth and strategic acquisitions.

• Juan Manuel Alba: An expert in international business development, Juan Manuel has been instrumental in expanding Prim, S.A.'s footprint in new markets.

• Ignacio Bravo Marín: Specializing in international relations, Ignacio has fostered key partnerships to enhance the company's global operations.

Key Contributions or Roles Within the Company

• Lucía Comenge: Guided the company through strategic acquisitions and operational improvements, leading to increased profitability and market share.

• Juan Manuel Alba: Expanded the company's presence in over 93 countries, including recent entries into Japan and China.

• Ignacio Bravo Marín: Established and maintained strategic partnerships, enhancing the company's international collaborations.

Leadership Changes

Recent Significant Changes or Appointments

• Succession Plan: In 2020, Prim, S.A. consolidated its succession plan, ensuring continuity in leadership and strategic direction.

Competitor Profile

Market Insights and Dynamics

The healthcare technology and mobility products sector is characterized by:

• Growth Potential: Increasing demand for innovative medical solutions and mobility aids.

• Industry Trends: Advancements in 3D printing, digitalization, and personalized healthcare products.

Competitor Analysis

Prim, S.A. faces competition from both domestic and international companies specializing in medical instruments and orthopedic supplies.